Chevron Corp (CVX): what the price requires

At today's price, Chevron Corp (CVX) is priced for +8.9% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-13 · Source: https://boothcheck.com/report/CVX

Headline

FieldValue
TickerCVX
CompanyChevron Corp
Current price$181.85/sh
CompositionUpstream U.S. 11% / Upstream International 18% / Downstream U.S. 35% / Downstream International 36% / All Other 0%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed5.9%
Operating margin today10.0%
Margin compression implied-4.1pp
Implied growth8.9%
Multiple paid19x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 8.5% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~6.8pp.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history+0.06σ
implied end-window share1%

Valuation X-Ray

Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset3.45x4expensive
Earnings2.73x2expensive
Relative1.86x3expensive
Growth1.90x5expensive

Families that call it expensive: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.

Per-Model Detail (n=14)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$63.132.88xyesFCF base $13.8B, growth -6% (input: historical growth), terminal g 0.5%, WACC 9.2%, 5yr projection
DCF Exit MultipleGrowth$153.291.19xyesExit EV/EBITDA: 11.8x / 16.8x / 21.8x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$97.681.86xyesP/E 16.84x (blended: sector 10x + trailing (TTM) 33x), scenarios: 12.6x / 16.8x / 20.2x (bear / base = sector held flat / bull), EV/EBITDA 9.25x
Simple DDMGrowth$231.080.79xyesDPS $7.10, g=6.0% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$19.849.17xyesStage 1: -34% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$59.933.03xyesBV/sh $92.51, ROE (TTM) 6.0%, ke 9.3%
Two-Stage Excess ReturnAsset$46.963.87xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$95.761.90xyesRev $190.0B, growth -6% (input: historical growth; tapered), Terminal P/S: 1.4x / 1.9x / 2.3x (bear / base = today's held flat / bull, cap 6x)
Growth-Adjusted P/ERelative——no—
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset$45.284.02xyesBV $92.51 + 5yr PV of (ROE (TTM) 6.0% − Kₑ 9.3%) × BV; BV grows 3.9%/yr
Graham NumberAsset$109.311.66xyes√(22.5 × EPS $5.74 × BVPS $92.51) — Graham's conservative floor
EV/EBITDA RelativeRelative$62.982.89xyesEBITDA $21.82B × sector EV/EBITDA 6.0x
FCF YieldEarnings$72.092.52xyesFCF $13781.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$4.8137.81xyesEPS $5.74 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative$114.831.58xyesRevenue $190.03B × sector P/S 1.2x
PEG Fair ValueRelative——no—
Earnings YieldEarnings$62.052.93xyesEPS $5.74 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net debt$14.7b
Net debt / NOPAT (after-tax)0.98x
Net debt / operating income (pre-tax)0.77x
Interest coverage15.9x
Share count CAGR (dilution)0.5%
Burning cashno

Bullet Takeaways

Bull Case

What the market is paying for here is durability of cash returns through a commodity cycle, and the bull case is that Chevron has built the machine to deliver exactly that. Production reached 3.7 million barrels of oil equivalent per day in 2025, up "12 percent higher than in 2024 primarily due to the acquisition of Hess" and the ramp at Tengiz, where the 10-K notes Chevron "ramped up total production to approximately 1 million barrels of oil-equivalent per day at Tengiz." Add a Permian position that has run above a million barrels a day for five straight quarters, and the volume base under the dividend is larger and more diversified than it was two years ago. More barrels at flat or rising prices is more cash, and Chevron has been explicit about where that cash goes.

The balance sheet is the quiet strength. Net debt of about $14.7 billion is under one year of operating profit, and interest is covered roughly fourteen times over. That is the kind of footing that lets a company keep buying back stock and paying a rising dividend when oil prices fall, which is precisely when peers without the cushion have to retrench. Chevron's board has the room to do it: the 10-K records a "Common Stock Repurchase Program" authorized in 2023 for "an aggregate amount of $75 billion." For 2026 management reaffirmed $2.5 to $3 billion of buybacks each quarter alongside the dividend, returning roughly $6 billion to shareholders in the first quarter alone, split between $3.5 billion of dividends and $2.5 billion of repurchases.

The business mix is more balanced than the "oil company" label suggests. By segment weight the company leans as much on downstream refining and marketing, in the United States and internationally, as on upstream production. That matters because downstream margins often widen when crude weakens, giving the consolidated result a partial natural hedge that a pure upstream producer lacks. A vertically integrated major with a 39-year dividend record, a $75 billion buyback authorization behind it, and a production base freshly enlarged by Hess is the kind of business that can keep compounding shareholder returns across the cycle rather than only at its peak.

Bear Case

Start with how the cash is being deployed, because that is where the bet is most visible. Chevron is committing $18 to $19 billion of capital spending in 2026 and another $10 to $12 billion a year to buybacks, all while carrying $14.7 billion of net debt, into a business whose revenue the company itself reported falling and whose product faces a structural demand question. The 10-K is candid that "evolving societal, investor and governmental pressure on companies to address ESG matters, and potential customer and consumer use of substitutes to Chevron's products" are real risks, naming "the pace of energy transition; customer and consumer preferences and the use of substitutes" among the forces that could erode demand. Returning capital aggressively is shareholder-friendly when the underlying asset is appreciating; it is a different decision when the long-run demand curve for the core product is contested.

The valuation methods are unusually unanimous against the current price, and that is the heart of the bear case. Group them and they all land below $173 (as of June 27, 2026): the asset-value methods built on a $92.51 book value and a trailing return on equity near 6%, the earnings-power methods that capitalize sustainable profit, the peer-multiple lens against other majors, and even the forward-growth cash-flow models. When no family of valuation method reaches the price, the price is a bet beyond what any standard frame supports. The conservative methods are usually the more honest read in that situation, and here the gap is wide, not marginal. The price is paying for a high-cycle outcome to persist.

The reason the methods look stretched is the reason a cyclical is dangerous at the peak: trailing earnings are not sustainable earnings. Q1 2026 illustrated it sharply. Reported earnings fell to $2.2 billion, or $1.11 per diluted share, from $3.5 billion a year earlier, with management attributing roughly $3 billion of unfavorable timing effects to a rise in commodity prices. The 10-K likewise flags "lower realizations, and lower downstream-related earnings from CPChem primarily due to lower chemicals margins" as drags on the result. A buyer at today's price is underwriting both a commodity price the company cannot set and a capital-return pace that depends on that commodity cooperating. If prices mean-revert toward mid-cycle, the same operating leverage that flatters the peak compresses the trough, and the buyback that looks like value at the high looks like spending into a declining asset.

Valuation

This report sets no fair value and no target. It starts from the $173.59 price and asks what that price assumes, then measures the distance to each way of valuing the business.

The first thing to read honestly is that no family of valuation method reaches the price. The asset-value methods, anchored on a $92.51 book value per share and a trailing return on equity near 6%, land well below it. The earnings-power methods, which capitalize current sustainable profit, land below it. The peer-multiple lens against other integrated majors lands below it. And the forward-growth cash-flow models, which credit projected output, land below it too. When every lens agrees the price is rich, the price is a bet that current conditions, not the through-cycle average, are the right anchor. For a commodity producer that distinction is everything: trailing profit reflects where oil happened to be, and the 6% return on equity in the data is a depressed-cycle figure, not a structural one.

Inverting the price tells the same story from the other direction. At today's level the market is paying roughly 18 times company-wide operating profit, which implies operating growth around 7% a year for five years. That pace is within what Chevron has recently delivered, helped by the Hess volumes, so the bet is less about an extraordinary growth rate and more about the cycle staying favorable long enough to sustain the cash machine. The right frame for a major is mid-cycle, not trailing: peak earnings are not sustainable earnings, and positioning on the cost curve and reserve life matter more than any single year's print.

Solvency is the floor under all of it. Net debt near $14.7 billion sits below a single year of operating profit, interest coverage runs about fourteen times, and the company is not burning cash. That is what lets Chevron defend the dividend and keep buying back shares when prices fall. The balance sheet does not make the price cheap on the conservative methods; it makes the downside survivable. A buyer is paying a high-cycle multiple for a fortress-balance-sheet major and trusting the cycle, and the integration of Hess, to carry the rest.

Catalysts

The most concrete near-term events are operational and tied to the Hess integration. In the first quarter of 2026 Chevron's production reached about 3.86 million barrels of oil equivalent per day, with U.S. output up 24% and global output up 15%, largely on Hess assets and Permian volumes that have stayed above a million barrels a day for five straight quarters. Adjusted earnings of about $2.8 billion, or $1.41 per share, beat the consensus near $0.97, even as reported earnings fell on roughly $3 billion of timing effects from rising commodity prices. The next quarterly print is the cleanest read on whether the enlarged production base is converting to cash as planned.

Capital-return cadence is the other catalyst, and it is unusually well telegraphed. Chevron reaffirmed full-year 2026 guidance of 7% to 10% production growth, $18 to $19 billion of capital spending, and $2.5 to $3 billion of buybacks per quarter, and extended its dividend-growth streak to a 39th consecutive year. Any change to that buyback pace, up on stronger prices or down on weaker ones, would be the signal that management's view of the cycle has shifted.

The overriding variable remains the commodity itself. Chevron does not set crude or chemical margins, and a sustained move in either direction will swing the timing effects, the realizations, and the downstream result far more than any operational milestone. That is the catalyst with the most leverage and the least predictability.

Peer Cohorts (Per Segment, With Filing Citations)

Upstream (reported)

Downstream (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Chevron first quarter 2026 results release · Chevron Q1 2026 earnings call, May 2026 · Chevron Q1 2026 results release

View the full interactive CVX report on boothcheck